News
Three MicroPort® Products Win iF Design Award in Berlin - 23 Apr 2022
Three products of MicroPort® have won the iF Design Award 2022....MicroPort NeuroTech™ Gets Marketing Approval for The X-Track™ Catheter - 17 Apr 2022
MicroPort NeuroTech™ has received marketing approval issued by China’s...Firehawk Liberty™ Receives Registration Approval in Peru - 16 Apr 2022
The Firehawk Liberty™ Rapamycin Target Eluting Coronary Stent System r...Endovastec™ Receives MDSAP Certificate for Brazil and Japan - 11 Apr 2022
Endovastec™ recently announced that it has received a Medical Device S...Robotic-Assisted Trans-bronchial Navigation System in First Clinical Trial - 07 Apr 2022
Expected to achieve early diagnosis and treatment for lung cancer...MicroPort® Announces Annual Results for 2021 - 31 Mar 2022
MicroPort® today announced the annual results of the Company and its s...MicroPort® MedBot® Announces Annual Results for 2021 - 30 Mar 2022
MicroPort® MedBot® today announced the annual results of the Company a...CardioFlow Medtech Announces Annual Results for 2021 - 29 Mar 2022
CardioFlow Medtech today announced the annual results of the Company a...Endovastec™ Announces Annual Results for 2021 - 29 Mar 2022
Endovastec™ today announced the annual results of the Company and its ...Lifesciences AutoEx® Chemotherapy Pump Gets NMPA Marketing Approval - 26 Mar 2022
MicroPort® Lifesciences has received marketing approval from NMPA for ...Hyperflex® Balloon Catheter Gets Marketing Approval in Japan - 25 Mar 2022
Endovastec™ recently announced that it has received registration appro...Orthopedics Gets Marketing Approval for Two Knee System Products - 23 Mar 2022
MicroPort® Orthopedics recently announced that it has received registr...Two MicroPort ® Products Receive Red Dot Design Award - 17 Mar 2022
MicroPort® recently announced that its two products have won the “Red ...HorizonMedical™’s CryoX™ Vitrification Device Approved for Marketing - 15 Mar 2022
HorizonMedical™ has announced that they have obtained medical device r...MicroPort® Enrolls First Patient in PROMISE-BIF Study to Investigate the Rapamycin Coronary Balloon Catheter for the Treatment of De Novo Coronary Artery Bifurcation Lesions - 12 Mar 2022
MicroPort® has announced the enrollment of the first patient in its PR...CardioFlow Medtech Gets Approval for Alwide® Plus Balloon Catheter - 10 Mar 2022
CardioFlow Medtech recently announced that their Alwide® Plus Balloon ...